Category: Include on Menu
-

BeyondSpring Secures FDA Fast Track Designation for Plinabulin as DUBLIN-4 Phase 3 Trial Advances
BeyondSpring received FDA Fast Track designation for Plinabulin plus docetaxel in post-ICI non-squamous NSCLC and announced a strategic transaction designed to reduce the cash required to advance its global Phase 3 DUBLIN-4 trial toward a prespecified interim analysis. Key Investor Takeaways Why BYSI Stock Is in Focus BeyondSpring has added both a regulatory catalyst and…
-

Vivos Therapeutics Targets $3.6 Million in Annual Cost Reductions as Revenue Growth Initiatives Accelerate
Vivos Therapeutics is implementing a restructuring plan targeting $3.6 million in annual savings while expanding several revenue initiatives that management believes could support cash flow positivity by late 2026 or early 2027. Key Investor Takeaways Why VVOS Stock Is in Focus Vivos Therapeutics is combining material operating expense reductions with several initiatives designed to increase…
-

Teads and Koddi Launch Global Retail Media Partnership Using OpenRTB Standard
Teads and Koddi have formed a global partnership designed to expand programmatic access to onsite retail media inventory, allowing advertisers to incorporate retailer advertising into broader omnichannel campaigns through a standardized OpenRTB framework. Key Investor Takeaways Why TEAD Stock Is in Focus Teads is expanding its retail media capabilities through a global integration with commerce…
-

Invivyd Reports Positive Phase 3 LIBERTY Results for VYD2311 and Plans Accelerated Approval Submission
Invivyd reported statistically significant Phase 3 safety and tolerability results for VYD2311 compared with an mRNA-based COVID-19 vaccine and said it plans to pursue an Accelerated Approval BLA pending supportive results from its ongoing DECLARATION study. Key Investor Takeaways Why IVVD Stock Is in Focus Invivyd’s Phase 3 LIBERTY study produced statistically significant results on…
-

Kraig Labs Ships First Commercial Spider Silk Order for Performance Textile Development
Kraig Biocraft Laboratories has shipped its first commercial recombinant spider silk yarn order to a globally recognized performance sports brand, moving its material into a customer product-development program for the first time. Key Investor Takeaways Why KBLB Stock Is in Focus Kraig Labs has reached a key commercialization milestone by shipping its first commercial order…
-

American Fusion Outlines Texatron Plasma Compression and Confinement Approach for Fusion Testing
American Fusion has detailed the theoretical physics behind its Texatron Fusion Engine, outlining how pulsed magnetic compression and a rifled chamber could potentially create and confine plasma while identifying the key performance requirements that still need experimental validation. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion has provided a more detailed technical…
-

Netlist Files New ITC Patent Action Against Micron Over HBM Technology for AI Computing
Netlist has filed a new U.S. International Trade Commission complaint seeking exclusion and cease and desist orders against Micron Technology and downstream customers Nvidia, Broadcom and Google over alleged infringement of two High Bandwidth Memory patents. Key Investor Takeaways Why NLST Stock Is in Focus Netlist has initiated another patent enforcement action against Micron, this…
-

Lightwave Logic Appoints Edward H. Kennedy to Board as Commercial Strategy Advances
Lightwave Logic has appointed telecom and networking executive Edward H. Kennedy to its Board of Directors, adding experience in corporate transformations, M&A and strategic alternatives as the company advances commercialization of its electro-optic polymer platform. Key Investor Takeaways Why LWLG Stock Is in Focus Lightwave Logic has expanded its board with the appointment of Edward…
-

ProText Mobility ABSA Digital-Asset Custody Pilot Advances RWA and Uplist Strategy
ProText Mobility says its chairman has been confirmed as the first pilot client in ABSA’s digital-asset custody onboarding process, adding an institutional custody component to the company’s broader real-world asset and regulated-exchange uplist strategy. Key Investor Takeaways Why TXTM Stock Is in Focus The central development in ProText Mobility’s shareholder update is the confirmation that…
-

Getchell Gold Secures $300,000 Strategic Investment for Fondaway Canyon Exploration
Getchell Gold is raising $300,000 from Buzbuzian Capital through a unit offering, providing additional funding for exploration at its flagship Fondaway Canyon gold project in Nevada. Key Investor Takeaways Why GGLDF Stock Is in Focus Getchell Gold announced that Buzbuzian Capital will invest $300,000 to acquire 1 million units of the company. The transaction implies…